{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:03:49Z","timestamp":1790553829350,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.jad.2009.12.014","type":"journal-article","created":{"date-parts":[[2010,1,19]],"date-time":"2010-01-19T10:48:03Z","timestamp":1263898083000},"page":"287-294","source":"Crossref","is-referenced-by-count":129,"title":["Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: Markers that further explain the higher incidence of neurodegeneration and coronary artery disease"],"prefix":"10.1016","volume":"125","author":[{"given":"Michael","family":"Maes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivanka","family":"Mihaylova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Kubera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Uytterhoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Vrydags","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Bosmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jad.2009.12.014_bib1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.5483\/BMBRep.2008.41.8.560","article-title":"Phospholipase A(2), reactive oxygen species, and lipid peroxidation in CNS pathologies","volume":"41","author":"Adibhatla","year":"2008","journal-title":"BMB Rep."},{"key":"10.1016\/j.jad.2009.12.014_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Text Revision (DSM-IV-TR)","author":"American Psychiatric Association","year":"2000"},{"issue":"1","key":"10.1016\/j.jad.2009.12.014_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.psychres.2006.03.025","article-title":"DNA damage in bipolar disorder","volume":"153","author":"Andreazza","year":"2007","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.jad.2009.12.014_bib4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s003910170019","article-title":"Lipid peroxidation as a common pathomechanism in coronary heart disease and Alzheimer disease","volume":"34","author":"Arlt","year":"2001","journal-title":"Z. Gerontol. Geriatr."},{"issue":"3","key":"10.1016\/j.jad.2009.12.014_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00041433-200206000-00009","article-title":"Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease","volume":"13","author":"Arlt","year":"2002","journal-title":"Curr. Opin. Lipidol."},{"issue":"6","key":"10.1016\/j.jad.2009.12.014_bib6","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","article-title":"N-acetyl cysteine for depressive symptoms in bipolar disorder\u2014a double-blind randomized placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2009.12.014_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00004714-200202000-00014","article-title":"Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system","volume":"22","author":"Bonaccorso","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2009.12.014_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.yco.0000194371.47685.f2","article-title":"An update on regional brain volume differences associated with mood disorders","volume":"19","author":"Campbell","year":"2006","journal-title":"Curr. Opin. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2009.12.014_bib9","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/PSY.0b013e31816a74de","article-title":"New onset depression following myocardial infarction predicts cardiac mortality","volume":"70","author":"Dickens","year":"2008","journal-title":"Psychosom. Med."},{"issue":"1","key":"10.1016\/j.jad.2009.12.014_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.psychres.2007.07.019","article-title":"Increased plasma levels of 8-iso-PGF2alpha and IL-6 in an elderly population with depression","volume":"161","author":"Dimopoulos","year":"2008","journal-title":"Psychiatry Res."},{"issue":"2\u20133","key":"10.1016\/j.jad.2009.12.014_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-0327(97)00166-3","article-title":"Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients","volume":"48","author":"Edwards","year":"1998","journal-title":"J. Affect. Disord."},{"issue":"7","key":"10.1016\/j.jad.2009.12.014_bib12","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s11064-007-9289-x","article-title":"Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain","volume":"32","author":"Eren","year":"2007","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.jad.2009.12.014_bib13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11064-006-9258-9","article-title":"Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat","volume":"32","author":"Eren","year":"2007","journal-title":"Neurochem. Res."},{"issue":"1\u20132","key":"10.1016\/j.jad.2009.12.014_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mrfmmm.2006.06.003","article-title":"Malondialdehyde, a major endogenous lipid peroxidation product, sensitizes human cells to UV- and BPDE-induced killing and mutagenesis through inhibition of nucleotide excision repair","volume":"601","author":"Feng","year":"2006","journal-title":"Mutat. Res."},{"issue":"1","key":"10.1016\/j.jad.2009.12.014_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.psy.0000195780.37277.2a","article-title":"Increased serum levels of 8-hydroxy-2\u2032-deoxyguanosine in clinical depression","volume":"68","author":"Forlenza","year":"2006","journal-title":"Psychosomatic Med."},{"issue":"3","key":"10.1016\/j.jad.2009.12.014_bib16","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1734-1140(09)70084-2","article-title":"Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment","volume":"61","author":"Galecki","year":"2009","journal-title":"Pharmacol. Rep."},{"issue":"13","key":"10.1016\/j.jad.2009.12.014_bib17","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/glia.20542","article-title":"Exposure of glia to pro-oxidant agents revealed selective Stat1 activation by H2O2 and Jak2-independent antioxidant features of the Jak2 inhibitor AG490","volume":"55","author":"Gorina","year":"2007","journal-title":"Glia"},{"issue":"7","key":"10.1016\/j.jad.2009.12.014_bib18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.mp.4002055","article-title":"Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression","volume":"13","author":"Goshen","year":"2008","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2009.12.014_bib19","first-page":"821","article-title":"Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease","volume":"55","author":"Gounopoulos","year":"2007","journal-title":"Minerva Cardioangiol."},{"key":"10.1016\/j.jad.2009.12.014_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2009.12.014_bib21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/glia.20596","article-title":"Activation of protein tyrosine kinases and matrix metalloproteinases causes blood\u2013brain barrier injury: novel mechanism for neurodegeneration associated with alcohol abuse","volume":"56","author":"Haorah","year":"2008","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.jad.2009.12.014_bib22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1440-1819.2009.01974.x","article-title":"Comorbidity of cardiovascular diseases with mood and anxiety disorder: a population based 4-year study","volume":"63","author":"Huang","year":"2009","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.jad.2009.12.014_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2004.05.021","article-title":"Antibodies to oxidized LDL in atherosclerosis development\u2014clinical and animal studies","volume":"348","author":"Hulthe","year":"2004","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.jad.2009.12.014_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cca.2005.01.005","article-title":"Gender differences in antioxidant capacity of rat tissues determined by 2, 2\u2032-azinobis (3-ethylbenzothiazoline 6-sulfonate; ABTS) and ferric reducing antioxidant power (FRAP) assays","volume":"140","author":"Katalinic","year":"2005","journal-title":"Comp. Biochem. Physiol. C. Toxicol. Pharmacol."},{"issue":"6","key":"10.1016\/j.jad.2009.12.014_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1179\/135100003225003393","article-title":"Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors","volume":"8","author":"Khanzode","year":"2003","journal-title":"Redox Rep."},{"key":"10.1016\/j.jad.2009.12.014_bib26","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1196\/annals.1361.086","article-title":"The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis","volume":"1051","author":"Kobayashi","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jad.2009.12.014_bib27","doi-asserted-by":"crossref","unstructured":"Kodydkov\u00e1, J., V\u00e1vrov\u00e1, L., Zeman, M., Jir\u00e1k, R., Mac\u00e1\u0161ek, J., Stankov\u00e1, B., Tvrzick\u00e1, E., Z\u00e1k, A., 2009. Antioxidative enzymes and increased oxidative stress in depressive women. Clin. Biochem. 42 (13\u201314), 1368\u20131374.","DOI":"10.1016\/j.clinbiochem.2009.06.006"},{"key":"10.1016\/j.jad.2009.12.014_bib28","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1073\/pnas.0708092105","article-title":"IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress","volume":"105","author":"Koo","year":"2008","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"issue":"5\u20136","key":"10.1016\/j.jad.2009.12.014_bib29","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.neuint.2009.01.001","article-title":"Effects of chronic mild stress on the oxidative parameters in the rat brain","volume":"54","author":"Lucca","year":"2009","journal-title":"Neurochem. Int."},{"issue":"9","key":"10.1016\/j.jad.2009.12.014_bib30","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jpsychires.2008.11.002","article-title":"Increased oxidative stress in submitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm","volume":"43","author":"Lucca","year":"2009","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.jad.2009.12.014_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0278-5846(94)00101-M","article-title":"Evidence for an immune response in major depression: a review and hypothesis","volume":"19","author":"Maes","year":"1995","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2009.12.014_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-0-585-37970-8_2","article-title":"Major depression and activation of the inflammatory response system","volume":"461","author":"Maes","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.jad.2009.12.014_bib33","first-page":"287","article-title":"The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression","volume":"29","author":"Maes","year":"2008","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.jad.2009.12.014_bib34","unstructured":"Maes, M., 2009. \u201cFunctional\u201d or \u201cpsychosomatic\u201d symptoms, e.g. a flu-like malaise, aches and pain and fatigue, are major features of major and in particular of melancholic depression: time to amend the diagnostic criteria for major depression and the rating scales that measure severity of illness. Neuro Endocrinol Lett. 30 (5) (nov)."},{"issue":"6","key":"10.1016\/j.jad.2009.12.014_bib35","first-page":"902","article-title":"Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: effects of age, duration of illness and the translocation of LPS from gram-negative bacteria","volume":"29","author":"Maes","year":"2008","journal-title":"Neuro Endocrinol. Lett."},{"issue":"3","key":"10.1016\/j.jad.2009.12.014_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000119472","article-title":"Immune disturbances during major depression: upregulated expression of interleukin-2 receptors","volume":"24","author":"Maes","year":"1990","journal-title":"Neuropsychobiology"},{"issue":"4","key":"10.1016\/j.jad.2009.12.014_bib37","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1600-0447.1991.tb03163.x","article-title":"Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production","volume":"84","author":"Maes","year":"1991","journal-title":"Acta Psychiatr. Scand."},{"issue":"5","key":"10.1016\/j.jad.2009.12.014_bib38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0006-3223(96)00365-4","article-title":"Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune\/inflammatory response in that illness","volume":"42","author":"Maes","year":"1997","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2009.12.014_bib39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0165-1781(99)00014-1","article-title":"Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients","volume":"85","author":"Maes","year":"1999","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.jad.2009.12.014_bib40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0165-0327(99)00121-4","article-title":"Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness","volume":"58","author":"Maes","year":"2000","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.jad.2009.12.014_bib41","first-page":"861","volume":"28","author":"Maes","year":"2007","journal-title":"Neuro Endocrinol. Lett."},{"issue":"1","key":"10.1016\/j.jad.2009.12.014_bib42","first-page":"117","article-title":"The gut\u2013brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression","volume":"29","author":"Maes","year":"2008","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.jad.2009.12.014_bib43","first-page":"313","volume":"29","author":"Maes","year":"2008","journal-title":"Neuro Endocrinol. Lett."},{"issue":"1","key":"10.1016\/j.jad.2009.12.014_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11011-008-9118-1","article-title":"The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression","volume":"24","author":"Maes","year":"2009","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.jad.2009.12.014_bib45","unstructured":"Maes, M., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., Bosmans, E., 2009b. Lower plasma coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuro Endocinol. Lett. 30 (4)."},{"key":"10.1016\/j.jad.2009.12.014_bib46","unstructured":"Maes, M., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., Bosmans, E., submitted for publication. GPX lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis\/chronic fatigue syndrome: lower GPX activity as another pathway explaining the increased incidence of coronary artery disease in depression. Neuro Endocrinol. Lett."},{"key":"10.1016\/j.jad.2009.12.014_bib47","unstructured":"Maes, M., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., Bosmans, E., 2009c. Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis\/chronic fatigue syndrome. Neuro Endocrinol Lett. 30 (6) (dec)."},{"key":"10.1016\/j.jad.2009.12.014_bib48","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/3-540-27661-0_27","article-title":"Autoimmune mechanisms of atherosclerosis","volume":"170","author":"Mandal","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"issue":"12","key":"10.1016\/j.jad.2009.12.014_bib49","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/NEN.0b013e31818e06f3","article-title":"Type-dependent oxidative damage in frontotemporal lobar degeneration: cortical astrocytes are targets of oxidative damage","volume":"67","author":"Mart\u00ednez","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"10","key":"10.1016\/j.jad.2009.12.014_bib50","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1177\/0961203308093553","article-title":"Autoimmune-mediated atherothrombosis","volume":"17","author":"Matsuura","year":"2008","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.jad.2009.12.014_bib51","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.autrev.2008.04.018","article-title":"Oxidation of LDL and its clinical implication","volume":"7","author":"Matsuura","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jad.2009.12.014_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15622970802123695","article-title":"Increased xanthine oxidase in the thalamus and putamen in depression","volume":"12","author":"Michel","year":"2008","journal-title":"World J. Biol. Psychiatry"},{"issue":"20","key":"10.1016\/j.jad.2009.12.014_bib53","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1016\/0006-2952(84)90083-2","article-title":"A novel biologically active seleno-organic compound\u2014I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen)","volume":"33","author":"M\u00fcller","year":"1984","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.jad.2009.12.014_bib54","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.ejcn.1602072","article-title":"Low plasma vitamin E levels in major depression: diet or disease?","volume":"59","author":"Owen","year":"2005","journal-title":"Eur. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.jad.2009.12.014_bib55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004850-200403000-00006","article-title":"Antioxidant enzyme activities and oxidative stress in affective disorders","volume":"19","author":"Ozcan","year":"2004","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jad.2009.12.014_bib56","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0091-3057(94)90191-0","article-title":"Glutathione as a cerebral substrate in depressive behavior","volume":"48","author":"Pal","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.jad.2009.12.014_bib57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejphar.2008.10.055","article-title":"Antidepressant-like effect of the organoselenium compound ebselen in mice: evidence for the involvement of the monoaminergic system","volume":"602","author":"Posser","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.jad.2009.12.014_bib58","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/glia.20467","article-title":"Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration","volume":"55","author":"Qin","year":"2007","journal-title":"Glia"},{"issue":"10","key":"10.1016\/j.jad.2009.12.014_bib59","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1021\/tx700248y","article-title":"Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediate","volume":"20","author":"Rees","year":"2007","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.jad.2009.12.014_bib60","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/hup.829","article-title":"Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative\u2013antioxidative systems","volume":"22","author":"Sarandol","year":"2007","journal-title":"Hum. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2009.12.014_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2004.04.055","article-title":"Protective effects on neuronal cells of mouse afforded by ebselen against oxidative stress at multiple steps","volume":"371","author":"Satoh","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.jad.2009.12.014_bib62","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pnpbp.2004.11.003","article-title":"Cytokines and major depression","volume":"29","author":"Schiepers","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2009.12.014_bib63","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neubiorev.2008.06.006","article-title":"Stress, depression, and coronary artery disease: modeling comorbidity in female primates","volume":"33","author":"Shively","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1\u20133","key":"10.1016\/j.jad.2009.12.014_bib64","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jad.2009.02.014","article-title":"Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study","volume":"118","author":"Siwek","year":"2009","journal-title":"J Affect. Disord."},{"issue":"2","key":"10.1016\/j.jad.2009.12.014_bib65","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000119692","article-title":"Depression and heart disease: therapeutic implications","volume":"111","author":"Somberg","year":"2008","journal-title":"Cardiology"},{"issue":"1","key":"10.1016\/j.jad.2009.12.014_bib66","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000119131","article-title":"Catalase, superoxide dismutase and glutathione peroxidase activity in neutrophils of sham-operated and olfactory-bulbectomised rats following chronic treatment with desipramine and lithium chloride","volume":"30","author":"Song","year":"1994","journal-title":"Neuropsychobiology"},{"issue":"2","key":"10.1016\/j.jad.2009.12.014_bib67","doi-asserted-by":"crossref","first-page":"131","DOI":"10.33549\/physiolres.930043","article-title":"Antibodies against oxidized LDL\u2014theory and clinical use","volume":"50","author":"Steinerov\u00e1","year":"2001","journal-title":"Physiol. Res."},{"issue":"9","key":"10.1016\/j.jad.2009.12.014_bib68","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.biopsych.2004.08.022","article-title":"Cellular changes in the postmortem hippocampus in major depression","volume":"56","author":"Stockmeier","year":"2004","journal-title":"Biol. Psychiatry"},{"issue":"11\u201312","key":"10.1016\/j.jad.2009.12.014_bib69","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1089\/ars.2006.8.2021","article-title":"Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics","volume":"8","author":"Sultana","year":"2006","journal-title":"Antioxid. Redox Signal."},{"issue":"11A","key":"10.1016\/j.jad.2009.12.014_bib70","doi-asserted-by":"crossref","first-page":"9P","DOI":"10.1016\/j.amjcard.2006.09.015","article-title":"Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease","volume":"98","author":"Tsimikas","year":"2006","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.jad.2009.12.014_bib71","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1191\/096120300678828280","article-title":"Antibodies to oxidised LDL","volume":"9","author":"Vaarala","year":"2000","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.jad.2009.12.014_bib72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/156652408784221306","article-title":"Molecular mechanisms and pathophysiology of necrotic cell death","volume":"8","author":"Vanlangenakker","year":"2008","journal-title":"Curr. Mol. Med."},{"issue":"5","key":"10.1016\/j.jad.2009.12.014_bib73","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1399-5618.2009.00717.x","article-title":"Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia","volume":"11","author":"Wang","year":"2009","journal-title":"Bipolar Disord."},{"issue":"3","key":"10.1016\/j.jad.2009.12.014_bib74","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jpsychores.2008.09.001","article-title":"The level of oxidative stress and the expression of genes involved in DNA-damage signaling pathways in depressive patients with colorectal carcinoma","volume":"66","author":"Wei","year":"2009","journal-title":"J. Psychosom. Res."},{"issue":"6","key":"10.1016\/j.jad.2009.12.014_bib75","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.mp.4001600","article-title":"IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity","volume":"10","author":"Wichers","year":"2005","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2009.12.014_bib76","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0022-3999(01)00315-4","article-title":"A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale)","volume":"52","author":"Zachrisson","year":"2002","journal-title":"J. Psychosom. Res."},{"issue":"5","key":"10.1016\/j.jad.2009.12.014_bib77","first-page":"872","article-title":"Relationship between oxidative stress and depression in patients with acute leukemia","volume":"14","author":"Zhou","year":"2006","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032709005667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032709005667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T20:57:53Z","timestamp":1739739473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032709005667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":77,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0165032709005667"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2009.12.014","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}